A macrolide antibiotic with diverse biological activities
Related Products And Services
Alternative(s)
11342Oligomycin A
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Oligomycin A (solution)

Item No. 46795

Product Insert (PDF)
Technical Information
Formal Name
(1R,2′R,4E,5′S,6S,6′S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-ethyl-3′,4′,5′,6′-tetrahydro-7,11,14,15-tetrahydroxy-6′-[(2R)-2-hydroxypropyl]-5′,6,8,10,12,14,16,28,29-nonamethyl-spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2′-[2H]pyran]-3,9,13-trione
CAS Number
579-13-5
Synonyms
  • MCH 32
Molecular Formula
C45H74O11
Formula Weight
Purity
≥95%
A 1 mM solution in DMSO
DMF: Soluble: ≥10 mg/mlDMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
O=C([C@H](C)[C@@H](O)[C@H](C)/C=C/1)[C@@H](C)[C@H](O)[C@@H](C)C([C@](O)(C)[C@H](O)[C@@H](C)C/C=C/C=C/[C@](CC)([H])CC[C@]2([H])[C@H](C)[C@]([C@@H](C)[C@]3(CC[C@@H](C)[C@](C[C@@H](O)C)([H])O3)O2)([H])OC1=O)=O
InChi Code
InChI=1S/C45H74O11/c1-12-34-17-15-13-14-16-27(4)42(51)44(11,53)43(52)32(9)40(50)31(8)39(49)30(7)38(48)26(3)18-21-37(47)54-41-29(6)35(20-19-34)55-45(33(41)10)23-22-25(2)36(56-45)24-28(5)46/h13-15,17-18,21,25-36,38,40-42,46,48,50-51,53H,12,16,19-20,22-24H2,1-11H3/b14-13+,17-15+,21-18+/t25-,26-,27+,28+,29+,30-,31-,32-,33-,34-,35-,36-,38+,40+,41+,42-,44+,45-/m1/s1
InChi Key
MNULEGDCPYONBU-WMBHJXFZSA-N
Origin
Microbial fermentation
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Oligomycin A is a polyketide-derived macrolide antibiotic originally isolated from S. diastatochromogenes that has diverse biological activities.1,2,3,4,5 It inhibits mitochondrial F1FO-ATP synthase by binding the FO subunit, preventing proton translocation, and uncoupling electron transport and ATP synthesis.2,3 Oligomycin A reduces the proliferation of K562 leukemia, HCT116 colorectal cancer, and MCF-7 breast cancer cells (IC50s = 0.2, 1, and 0.44 µM, respectively).4,5 It is active against S. fradiae, C. kruesi, and fluconazole-sensitive and -resistant C. albicans (MICs = 0.05, 2, 4, and 32 µg/ml, respectively).5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Carter, G.T. Structure determination of oligomycins A and C. Am. Chem. Soc. 51(22), 4264-4271 (1986).

    2. Nafie, M.S., Alshams, M.A., Diab, M.K., et al. Beyond ATP synthase inhibition: Chemical diversification, bioactivities, and therapeutic potential of oligomycin A. Chem. Biol. Drug Des. 106(4), e70173 (2025).

    3. Salomon, A.R., Voehringer, D.W., Herzenberg, L.A., et al. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase. Chem. Biol. 8(1), 71-80 (2001).

    4. Lysenkova, L.N., Turchin, K.F., Korolev, A.M., et al. Synthesis and cytotoxicity of oligomycin A derivatives modified in the side chain. Bioorg. Med. Chem. 21(11), 2918-2924 (2013).

    5. Lysenkova, L.N., Saveljev, O.Y., Omelchuk, O.A., et al. Synthesis, antimicrobial and antiproliferative properties of epi-oligomycin A, the (33S)-diastereomer of oligomycin A. Nat. Prod. Res. 34(21), 3073-3081 (2020).